hepatitis b virus (hbv) infection a silent epidemic
DESCRIPTION
Myanmar is one of the countries with high HBV prevalence. Compared to other diseases like TB, HIV and malaria, HBV received less attention than it should to be educated, tested, vaccinated and treated.TRANSCRIPT
![Page 1: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/1.jpg)
HealthCamp – BarCampX Yangon 2012 MICT Park, Hlaing, Yangon 5th August 2012
Hepatitis B Virus (HBV) Infection: A Silent Epidemic
Aung Zayar Paing M.B.,B.S.
![Page 2: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/2.jpg)
BC 2000 - Some ancient records showed epidemic of hepatitis.
1883 - Lurman found that people vaccinated for small pox with lymph from other people suffered from hepatitis (known as serum hepatitis at that time).
• Many similar outbreaks happened when treating syphilis with reused needles in 1909.
• Most probably due to Hepatitis B.
1965 - Baruch Blumberg discovered ‘Australian antigen (now known as HBs Antigen)
1970 - D.S. Dane and others discovered the virus particle with electron microscope.
![Page 3: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/3.jpg)
1980-81 – HBV vaccine derived from serum was developed by Hilleman and collegues, proved effective and licensed for use.
1983-86 - William Rutter and colleagues developed HBV vaccine derived from yeast using recombinant DNA technology.
2010 – Clément Gilbert and Cédric Feschotte found the fragments of HBV genes in the 19-millions-old fossils of songbirds.
2012 - Korean and Islraeli scientists can map the entire genome of HBV found in the preserved liver of 16th century Korean mummified child.
![Page 4: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/4.jpg)
![Page 5: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/5.jpg)
About 2 billion people have been infected with HBV infection around the world.
> 2 million people have chronic HBV infection.
About 600 000 die every year due to the acute and chronic consequences of HBV. (WHO 2012)
About 25% (20-30%) of chronic infection results in cirrhosis or liver cancer.
![Page 6: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/6.jpg)
Prevalence of HBs Antigen, 2006 (CDC)
![Page 7: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/7.jpg)
Myanmar is one of the countries with high HBV burden.
HBV prevalence rate in Myanmar varies from study to study.
o It varies from 8 – 12%. (Healthy people)
Based on the population of Myanmar, disease burden can be calculated as follows:
o Population: 48,000,000 (48 million)(World Bank 2011)
o Disease burden: 3,840,000 to 5,760,000
![Page 8: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/8.jpg)
![Page 9: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/9.jpg)
![Page 10: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/10.jpg)
![Page 11: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/11.jpg)
HBV is a member of smallest virus family Hepadnaviridae
It measures 42 nm.
It can survive for 15 years at -20ºC, for 24 months at -80ºC, for 6 months at room tempature, and 7 days at 44ºC.
• Some said that it can be inactivated in 10 minutes when heated at 80ºC.
HBV is 100 times more infectious than HIV. (Very minute amount of blood can be infectious.)
![Page 12: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/12.jpg)
![Page 13: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/13.jpg)
Name Abbreviation Definition/Comment
Hepatitis B Surface Antigen HBsAg Antigen indicating infection
HBV Deoxyribonucleic Acid HBV DNA Indicates active viral replication
Alanine Aminotransferase ALT An enzyme produced in the liver. Increases in ALT levels are often associated with liver cell inflammation or liver cell injury
Hepatitis B Core Antibody anti-HBc Appears at the onset of symptoms in acute hepatitis B and persists for life. It indicates previous or ongoing infection with hepatitis B virus (HBV)
Hepatitis B Surface Antibody anti-HBs Usually indicates immunity
Hepatitis B e Antigen HBeAg Antigen correlating with HBV replication and infectivity, but low or undetectable in patients with precore or core mutation
Hepatitis B e Antibody anti-HBe Usually appear in early recovery stage before anti-HBs
HBeAg negative chronic Hepatitis B
-variant of HBV which has mutation in precore region. HBV DNA is high with HBeAg negative.
![Page 14: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/14.jpg)
Pict
ure
sour
ce: N
EJM
Durable!!! It persists
even in successfully
treated patients
waiting for a chance to reactivate
![Page 15: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/15.jpg)
![Page 16: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/16.jpg)
Picture source: CCO Hepatology inPractice
![Page 17: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/17.jpg)
Transmitted by blood, semen and vaginal fluid of an infected person.
o Unprotected sexual contact with infected person
o Infectious blood and blood related instruments
• Blood transfusion
• Unsterilized/under-sterilized needles and syringes
• Needle stick injury
• Toothbrush and razor
o From mother to child (esp. during childbirth) (Common in South-East Asia)
![Page 18: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/18.jpg)
Grammatically it’s just a simple ‘Yes or No’ question.
However medically or scientifically, it cannot be answered simply with ‘Yes’ or ‘No’.
![Page 19: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/19.jpg)
Transmission through saliva
• CDC factsheet about HBV doesn’t include saliva as an infectious source. (Hepatitis B General information, Hepatitis B Are you at risk?: CDC June 2010)
• WHO HBV factsheet mentions only blood, semen and vaginal fluid as infectious. (Hepatitis Fact sheet N°204, July 2012)
• Let’s explore more …
![Page 20: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/20.jpg)
![Page 21: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/21.jpg)
![Page 22: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/22.jpg)
![Page 23: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/23.jpg)
Generally speaking risk of infection increases if the donor has high HBV DNA load and replication.
For transmission through saliva, the chance of getting infection increases in following conditions:
o Infected saliva mixed with blood
o Non-intact skin or mucosa (inflammation, cut, etc)
o High HBV DNA load in saliva
![Page 24: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/24.jpg)
Acute Hepatitis B It refers to the conditions following transmission of HBV.
Usually lasts for 4-8 weeks.
Two third (2/3) of patients are asymptomatic. (don’t suffer from anything)
Chance of progression to chronic HBV depends on age of acquiring HBV.
![Page 25: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/25.jpg)
![Page 26: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/26.jpg)
Chronic Hepatitis B • HBsAg-positive >6 months
• Serum HBV DNA >20,000 IU/mL (105copies/mL), lower values 2,000-20,000 IU/mL (104-105 copies/mL) are often seen in HBeAg-negative chronic hepatitis B
• Persistent or intermittent elevation in ALT/AST levels
• Liver biopsy showing chronic hepatitis with moderate or severenecroinflammation (AASLD: Chronic Hepatitis B: Update 2009)
![Page 27: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/27.jpg)
Chronic Hepatitis B
• Chronic HBV patients (chronic carrier) may feel healthy without having any illness for long time.
• To know the disease progression and need for treatment
• ALT, Ultrasound should be checked every 3-6 months.
• If available and affordable, better to check HBV DNA.
• Should avoid risk factors (alcohol, smoking, liver toxic agents) and should be vaccinated against Hepatitis A & E.)
• If HBV DNA is high enough to start treatment, decreasing HBV DNA with drugs is needed to prevent further liver damage from HBV.
![Page 28: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/28.jpg)
Common in SEA
![Page 29: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/29.jpg)
Risks of Chronic Hepatitis B • Progress of chronic hepatitis B to cirrhosis and Liver cancer
can be as high as 20-30%.
• Factors influencing disease progress are:
• High HBV DNA in blood
• Precore mutant HBV (HBe Ag negative chronic HBV)
• Male patients
• Alcohol and other hepatotoxic agents/drugs use
• Smoking
• Coinfection with HIV and/or HCV
• Genotype of HBV (e.g., genotype C)
• Immune status of the patient
![Page 30: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/30.jpg)
Tests
• Anyone should get tested for HBsAg.
• If HBsAg is positive for first time, recheck HBsAg after 6 months.
• If HBsAg is negative, check anti-HBs Antibody.
• If anti-HBs Ab is ≥ 10 IU/L, vaccination is not needed.
• If anti-HBs Ab is negative or ≤ 10 IU/L, vaccination should be started.
![Page 31: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/31.jpg)
Avoidance of risk factors
Vaccination
Anti-viral drugs administration to mother and immunoprophylaxis (HBIG) to baby (for HBs Ag + mother)
Prevention of occupational and non-occupational exposures
![Page 32: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/32.jpg)
Vaccination
• Actually HBV vaccine is the introduction of HBsAg to the body to illicit immune response to HBV infection.
• It has to be administered 3-4 doses to make our immune system to remember the incoming enemy.
• After 3 doses, anti-HBs antibody level needs to be checked to assess if you have enough protection.
![Page 33: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/33.jpg)
Vaccine schedule for Babies
![Page 34: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/34.jpg)
Vaccination schedule for children, adolescents and adults
CD
C: M
MW
R 2
005;
54(N
o. R
R-1
6)
![Page 35: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/35.jpg)
Prevention of mother-to-child transmission
• Antiviral drugs are not usually needed to prevent transmission to baby from infected mother.
• Nucleos(t)ide analogues are recommended to start at last 3 months of pregnancy only if maternal HBV DNA is high and HBeAg (+).
• Every baby born to HBsAg has to be vaccinated with both Hepatitis B Immunoglobulin (HBIG) and Hepatiti B vaccine.
• Babies who had prophylaxis and vaccine are unlikely to get HBV from breastfeeding.
![Page 36: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/36.jpg)
![Page 37: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/37.jpg)
Acute HBV infection is not usually treated with anti-virals
Indications for treatment depends on:
o Serum HBV DNA levels. (HBV DNA level to treat varies from guideline to guideline) (≥ 2000 - > 20,000 IU/mL)
o Serum ALT levels.
o Severity of liver fibrosis (scarring)
![Page 38: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/38.jpg)
![Page 39: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/39.jpg)
2 types of treatment regimens can be chosen
Interferon therapy Nucleos(t)ide analogues (NAs)
Advantages Finite duration Potent anti-viral effect
Absence of resistance Fewer side effects
Higher rates of anti-HBe & anti-HBs seroconversion with 12 mo of therapy
Oral administration
Better to choose for patient coinfected with HCV
TDF is also active against HIV.
Disadvantages Moderate anti-viral effect Infinite duration
Substantial side effects Risk of resistance
Sub-cutaneous injection Lower rate of HBeAg & HBs Ag loss
Cannot be used in cirrhosis and liver failure
![Page 40: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/40.jpg)
Available drugs for HBV treatment
• Interferons o Interferon alfa (IFN-a)
o Pegylated interferon alfa 2a (Peg-IFN-a 2a)
• Nucleos(t)ide analogues (NA) o Tenofovir (also useful in patients resistant to other NAs)
o Entecavir
o Lamivudine
o Adefovir
o Telbivudine
These are not recommended for initial monotherapy
![Page 41: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/41.jpg)
Conclusion • Myanmar is one of the countries with high HBV
prevalence. (8-12%) • HBV Genotype C (common in Myanmar) has high
risk of bad outcomes. • Anyone should be tested for HBsAg. (Most chronic
hepatitis B infected patients don’t know that they carries the virus.)
• Vaccination is the best prevention. (including immuoprophylaxis for babies)
• Chance of progressing to chronic hepatitis B increases when acquiring HBV in young age. (It’s commonest in South-East Asia.)
![Page 42: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/42.jpg)
Conclusion (2) • Chronic carriers (Chronic Hepatitis B) should be routinely
checked for disease progress and need to be treated.
o They should avoid alcohol, smoking and get vaccinated for other hepatitis viruses. (Hepatitis A and E.)
o 20-30% of chronic carrier can progress to cirrhosis and liver cancer.
o Identification of chronic hepatitis B patients is important to prevent bad outcomes.
• Anyone who are exposed to HBV infection are at risk of HBV reactivation when immune system is compromised. (esp. with steroid therapy and anti-cancer drugs)
![Page 43: Hepatitis b virus (hbv) infection a silent epidemic](https://reader034.vdocuments.site/reader034/viewer/2022052307/554b62e6b4c9051b458b52ac/html5/thumbnails/43.jpg)
July 28 is World Hepatitis Day.
Let’s get tested, vaccinated and treated!!!
Email: [email protected]